Fast facts: Bladder cancer:
"Our understanding of the biology of bladder cancer has advanced remarkably since the second edition of 'Fast Facts: Bladder Cancer' was published in 2006. Five new immunotherapies targeting the PD-1 axis were approved in 2016 and 2017 for the treatment of advanced bladder cancer, ref...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Abingdon, Oxon
Health Press
2018
|
Ausgabe: | Third edition |
Schriftenreihe: | Fast Facts
|
Schlagworte: | |
Online-Zugang: | Volltext Volltext |
Zusammenfassung: | "Our understanding of the biology of bladder cancer has advanced remarkably since the second edition of 'Fast Facts: Bladder Cancer' was published in 2006. Five new immunotherapies targeting the PD-1 axis were approved in 2016 and 2017 for the treatment of advanced bladder cancer, reflecting this transformative explosion in knowledge about the biology of the disease. This new era of targeted treatment offers hope to patients, particularly those with advanced disease. However, for clinicians it means a lot to understand in terms of how these immunotherapies are integrated into the treatment paradigm. Who they are suitable for? When are they best used? What is the optimal sequence of treatments for individual patients?This third edition of 'Fast Facts: Bladder Cancer' has been updated extensively throughout by two new authors, bringing a fresh perspective. Key updates include:" the latest understanding of pathology and biology" current standards for investigation, imaging and diagnosis" the critical role that awareness of the significance of hematuria among patients and primary care health professionals can make to earlier detection at curable stages of the disease" the roles of drugs, surgery and radiation therapy in treatment at different stages of bladder cancer, and when and how best to intervene, aided by understanding of the risk factors for disease relapse and progression" a new chapter about immunotherapy for bladder cancer" future trends in a rapidly evolving field.'Fast Facts: Bladder Cancer' is a concise guide that will be of value to clinicians and health professionals involved in the detection and treatment of bladder cancer. This highly readable resource provides a comprehensive and current view of this complex disease, enabling informed discussions with patients."--Website publisher |
Beschreibung: | 1 Online-Ressource color illustrations |
ISBN: | 1910797642 1910797650 1910797669 9781910797648 9781910797655 9781910797662 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV048279336 | ||
003 | DE-604 | ||
005 | 20241219 | ||
007 | cr|uuu---uuuuu | ||
008 | 220610s2018 xx a||| ob||| 00||| eng d | ||
020 | |a 1910797642 |q (electronic bk.) |9 1910797642 | ||
020 | |a 1910797650 |q (electronic bk.) |9 1910797650 | ||
020 | |a 1910797669 |q (electronic bk.) |9 1910797669 | ||
020 | |a 9781910797648 |q (electronic bk.) |9 9781910797648 | ||
020 | |a 9781910797655 |q (electronic bk.) |9 9781910797655 | ||
020 | |a 9781910797662 |q (electronic bk.) |9 9781910797662 | ||
020 | |z 1910797642 |9 1910797642 | ||
020 | |z 9781910797648 |9 9781910797648 | ||
035 | |a (OCoLC)1028848893 | ||
035 | |a (DE-599)BVBBV048279336 | ||
040 | |a DE-604 |b ger | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-384 | ||
100 | 1 | |a Lerner, Seth P. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Fast facts: Bladder cancer |c Seth P. Lerner, Ian D. Davis |
246 | 1 | 3 | |a Bladder cancer |
246 | 1 | 0 | |a Bladder cancer |
250 | |a Third edition | ||
264 | 1 | |a Abingdon, Oxon |b Health Press |c 2018 | |
300 | |a 1 Online-Ressource |b color illustrations | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Fast Facts | |
505 | 8 | |a "Epidemiology and etiology " Pathology and biology " Clinical presentation " Investigations " Management of non-muscle-invasive disease " Management of muscle-invasive disease " Management of advanced and metastatic disease " Immunotherapy " Future trends " Useful resources | |
520 | 3 | |a "Our understanding of the biology of bladder cancer has advanced remarkably since the second edition of 'Fast Facts: Bladder Cancer' was published in 2006. Five new immunotherapies targeting the PD-1 axis were approved in 2016 and 2017 for the treatment of advanced bladder cancer, reflecting this transformative explosion in knowledge about the biology of the disease. This new era of targeted treatment offers hope to patients, particularly those with advanced disease. However, for clinicians it means a lot to understand in terms of how these immunotherapies are integrated into the treatment paradigm. Who they are suitable for? When are they best used? What is the optimal sequence of treatments for individual patients?This third edition of 'Fast Facts: Bladder Cancer' has been updated extensively throughout by two new authors, bringing a fresh perspective. Key updates include:" the latest understanding of pathology and biology" current standards for investigation, imaging and diagnosis" the critical role that awareness of the significance of hematuria among patients and primary care health professionals can make to earlier detection at curable stages of the disease" the roles of drugs, surgery and radiation therapy in treatment at different stages of bladder cancer, and when and how best to intervene, aided by understanding of the risk factors for disease relapse and progression" a new chapter about immunotherapy for bladder cancer" future trends in a rapidly evolving field.'Fast Facts: Bladder Cancer' is a concise guide that will be of value to clinicians and health professionals involved in the detection and treatment of bladder cancer. This highly readable resource provides a comprehensive and current view of this complex disease, enabling informed discussions with patients."--Website publisher | |
650 | 7 | |a Vessie |2 Cancer | |
650 | 7 | |a Bladder |2 Cancer | |
650 | 7 | |a Bladder |2 Cancer | |
650 | 7 | |a HEALTH & FITNESS |2 Diseases | |
650 | 7 | |a MEDICAL |2 Clinical Medicine | |
650 | 7 | |a MEDICAL |2 Diseases | |
650 | 7 | |a MEDICAL |2 Evidence-Based Medicine | |
650 | 7 | |a MEDICAL |2 Internal Medicine | |
650 | 4 | |a Blaaskanker | |
650 | 4 | |a Bladder |x Cancer |x Diagnosis | |
650 | 4 | |a Bladder |x Cancer |x Treatment | |
653 | 6 | |a Electronic books | |
700 | 1 | |a Davis, Ian D. |e Sonstige |4 oth | |
856 | 4 | 0 | |u https://karger.com/books/book/356 |x Verlag |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1730434 |x Verlag |z kostenfrei |3 Volltext |
912 | |a ZDB-4-EOAC | ||
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-033659501 |
Datensatz im Suchindex
_version_ | 1818858712532516864 |
---|---|
adam_text | |
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Lerner, Seth P. |
author_facet | Lerner, Seth P. |
author_role | aut |
author_sort | Lerner, Seth P. |
author_variant | s p l sp spl |
building | Verbundindex |
bvnumber | BV048279336 |
collection | ZDB-4-EOAC |
contents | "Epidemiology and etiology " Pathology and biology " Clinical presentation " Investigations " Management of non-muscle-invasive disease " Management of muscle-invasive disease " Management of advanced and metastatic disease " Immunotherapy " Future trends " Useful resources |
ctrlnum | (OCoLC)1028848893 (DE-599)BVBBV048279336 |
edition | Third edition |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV048279336</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20241219</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220610s2018 xx a||| ob||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1910797642</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">1910797642</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1910797650</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">1910797650</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1910797669</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">1910797669</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781910797648</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">9781910797648</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781910797655</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">9781910797655</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781910797662</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">9781910797662</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1910797642</subfield><subfield code="9">1910797642</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781910797648</subfield><subfield code="9">9781910797648</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1028848893</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048279336</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-384</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lerner, Seth P.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Fast facts: Bladder cancer</subfield><subfield code="c">Seth P. Lerner, Ian D. Davis</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Bladder cancer</subfield></datafield><datafield tag="246" ind1="1" ind2="0"><subfield code="a">Bladder cancer</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Third edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Abingdon, Oxon</subfield><subfield code="b">Health Press</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield><subfield code="b">color illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Fast Facts</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">"Epidemiology and etiology " Pathology and biology " Clinical presentation " Investigations " Management of non-muscle-invasive disease " Management of muscle-invasive disease " Management of advanced and metastatic disease " Immunotherapy " Future trends " Useful resources</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"Our understanding of the biology of bladder cancer has advanced remarkably since the second edition of 'Fast Facts: Bladder Cancer' was published in 2006. Five new immunotherapies targeting the PD-1 axis were approved in 2016 and 2017 for the treatment of advanced bladder cancer, reflecting this transformative explosion in knowledge about the biology of the disease. This new era of targeted treatment offers hope to patients, particularly those with advanced disease. However, for clinicians it means a lot to understand in terms of how these immunotherapies are integrated into the treatment paradigm. Who they are suitable for? When are they best used? What is the optimal sequence of treatments for individual patients?This third edition of 'Fast Facts: Bladder Cancer' has been updated extensively throughout by two new authors, bringing a fresh perspective. Key updates include:" the latest understanding of pathology and biology" current standards for investigation, imaging and diagnosis" the critical role that awareness of the significance of hematuria among patients and primary care health professionals can make to earlier detection at curable stages of the disease" the roles of drugs, surgery and radiation therapy in treatment at different stages of bladder cancer, and when and how best to intervene, aided by understanding of the risk factors for disease relapse and progression" a new chapter about immunotherapy for bladder cancer" future trends in a rapidly evolving field.'Fast Facts: Bladder Cancer' is a concise guide that will be of value to clinicians and health professionals involved in the detection and treatment of bladder cancer. This highly readable resource provides a comprehensive and current view of this complex disease, enabling informed discussions with patients."--Website publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vessie</subfield><subfield code="2">Cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bladder</subfield><subfield code="2">Cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bladder</subfield><subfield code="2">Cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="2">Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="2">Clinical Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="2">Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="2">Evidence-Based Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="2">Internal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blaaskanker</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bladder</subfield><subfield code="x">Cancer</subfield><subfield code="x">Diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bladder</subfield><subfield code="x">Cancer</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="653" ind1=" " ind2="6"><subfield code="a">Electronic books</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Davis, Ian D.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://karger.com/books/book/356</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1730434</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EOAC</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033659501</subfield></datafield></record></collection> |
id | DE-604.BV048279336 |
illustrated | Illustrated |
index_date | 2024-07-03T20:00:50Z |
indexdate | 2024-12-19T09:00:38Z |
institution | BVB |
isbn | 1910797642 1910797650 1910797669 9781910797648 9781910797655 9781910797662 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033659501 |
oclc_num | 1028848893 |
open_access_boolean | 1 |
owner | DE-355 DE-BY-UBR DE-384 |
owner_facet | DE-355 DE-BY-UBR DE-384 |
physical | 1 Online-Ressource color illustrations |
psigel | ZDB-4-EOAC |
publishDate | 2018 |
publishDateSearch | 2018 |
publishDateSort | 2018 |
publisher | Health Press |
record_format | marc |
series2 | Fast Facts |
spelling | Lerner, Seth P. Verfasser aut Fast facts: Bladder cancer Seth P. Lerner, Ian D. Davis Bladder cancer Third edition Abingdon, Oxon Health Press 2018 1 Online-Ressource color illustrations txt rdacontent c rdamedia cr rdacarrier Fast Facts "Epidemiology and etiology " Pathology and biology " Clinical presentation " Investigations " Management of non-muscle-invasive disease " Management of muscle-invasive disease " Management of advanced and metastatic disease " Immunotherapy " Future trends " Useful resources "Our understanding of the biology of bladder cancer has advanced remarkably since the second edition of 'Fast Facts: Bladder Cancer' was published in 2006. Five new immunotherapies targeting the PD-1 axis were approved in 2016 and 2017 for the treatment of advanced bladder cancer, reflecting this transformative explosion in knowledge about the biology of the disease. This new era of targeted treatment offers hope to patients, particularly those with advanced disease. However, for clinicians it means a lot to understand in terms of how these immunotherapies are integrated into the treatment paradigm. Who they are suitable for? When are they best used? What is the optimal sequence of treatments for individual patients?This third edition of 'Fast Facts: Bladder Cancer' has been updated extensively throughout by two new authors, bringing a fresh perspective. Key updates include:" the latest understanding of pathology and biology" current standards for investigation, imaging and diagnosis" the critical role that awareness of the significance of hematuria among patients and primary care health professionals can make to earlier detection at curable stages of the disease" the roles of drugs, surgery and radiation therapy in treatment at different stages of bladder cancer, and when and how best to intervene, aided by understanding of the risk factors for disease relapse and progression" a new chapter about immunotherapy for bladder cancer" future trends in a rapidly evolving field.'Fast Facts: Bladder Cancer' is a concise guide that will be of value to clinicians and health professionals involved in the detection and treatment of bladder cancer. This highly readable resource provides a comprehensive and current view of this complex disease, enabling informed discussions with patients."--Website publisher Vessie Cancer Bladder Cancer HEALTH & FITNESS Diseases MEDICAL Clinical Medicine MEDICAL Diseases MEDICAL Evidence-Based Medicine MEDICAL Internal Medicine Blaaskanker Bladder Cancer Diagnosis Bladder Cancer Treatment Electronic books Davis, Ian D. Sonstige oth https://karger.com/books/book/356 Verlag kostenfrei Volltext https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1730434 Verlag kostenfrei Volltext |
spellingShingle | Lerner, Seth P. Fast facts: Bladder cancer "Epidemiology and etiology " Pathology and biology " Clinical presentation " Investigations " Management of non-muscle-invasive disease " Management of muscle-invasive disease " Management of advanced and metastatic disease " Immunotherapy " Future trends " Useful resources Vessie Cancer Bladder Cancer HEALTH & FITNESS Diseases MEDICAL Clinical Medicine MEDICAL Diseases MEDICAL Evidence-Based Medicine MEDICAL Internal Medicine Blaaskanker Bladder Cancer Diagnosis Bladder Cancer Treatment |
title | Fast facts: Bladder cancer |
title_alt | Bladder cancer |
title_auth | Fast facts: Bladder cancer |
title_exact_search | Fast facts: Bladder cancer |
title_exact_search_txtP | Fast facts |
title_full | Fast facts: Bladder cancer Seth P. Lerner, Ian D. Davis |
title_fullStr | Fast facts: Bladder cancer Seth P. Lerner, Ian D. Davis |
title_full_unstemmed | Fast facts: Bladder cancer Seth P. Lerner, Ian D. Davis |
title_short | Fast facts: Bladder cancer |
title_sort | fast facts bladder cancer |
topic | Vessie Cancer Bladder Cancer HEALTH & FITNESS Diseases MEDICAL Clinical Medicine MEDICAL Diseases MEDICAL Evidence-Based Medicine MEDICAL Internal Medicine Blaaskanker Bladder Cancer Diagnosis Bladder Cancer Treatment |
topic_facet | Vessie Bladder HEALTH & FITNESS MEDICAL Blaaskanker Bladder Cancer Diagnosis Bladder Cancer Treatment |
url | https://karger.com/books/book/356 https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1730434 |
work_keys_str_mv | AT lernersethp fastfactsbladdercancer AT davisiand fastfactsbladdercancer AT lernersethp bladdercancer AT davisiand bladdercancer |